Fundraising FoxSignalRX Pharmaceuticals
Cumming, US · Delaware corporation
Find your way into SignalRX Pharmaceuticals
Sign up to see every warm intro you have to SignalRX Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SignalRX Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MW
Matthew WilliamsDirector and Chief Executive Officer
GM
Guillermo MoralesNamed on SEC filing
JW
Joel WernickNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2022
▶$250KraisedMay 2023 · 2 investors · PharmaceuticalsRule 506(b)
▶$250KraisedMay 2023 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Guillermo MoralesDirector
- Joel WernickDirector
- Matthew WilliamsExecutive Officer, Director
- Offering amount
- $485K
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as SignalRX Pharmaceuticals.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2017 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2015 | $209K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- How much funding has SignalRX Pharmaceuticals raised?
- SignalRX Pharmaceuticals has disclosed $250K raised across 1 round.
- Where is SignalRX Pharmaceuticals headquartered?
- SignalRX Pharmaceuticals is headquartered in Cumming, US.